Botulinum Neurotoxin (BoNT) B Substrate Modification (amide) - FITC labeled

<strong>Botulinum Neurotoxin (BoNT) B Substrate Modification (amide) - FITC labeled</strong>_x000D_ <strong>Catalog number:</strong> B2019512_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 4516_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> FITC-LC-LSELDDRADALQAGASQFESSAAKLKRKYWWKNLK-NH2_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Elliott M, Maignel J, Liu SM, Favre-Guilmard C, Mir I, Farrow P, Hornby F, Marlin S, Palan S, Beard M, Krupp J. Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems PLoS One. 2017 Oct 5;12(10):e0185628._x000D_ 2: Yi KH, Lee JH, Lee K, Hu HW, Lee HJ, Kim HJ. Anatomical Proposal for Botulinum Neurotoxin Injection Targeting the Platysma Muscle for Treating Platysmal Band and Jawline Lifting: A Review Toxins (Basel). 2022 Dec 10;14(12):868._x000D_ 3: Yi KH, Lee JH, Hu HW, Kim HJ. Anatomical Proposal for Botulinum Neurotoxin Injection for Glabellar Frown Lines Toxins (Basel). 2022 Apr 10;14(4):268._x000D_ 4: Yeung W, Richards AL, Novakovic D. Botulinum Neurotoxin Therapy in the Clinical Management of Laryngeal Dystonia Toxins (Basel). 2022 Dec 1;14(12):844._x000D_ 5: Dong M, Masuyer G, Stenmark P. Botulinum and Tetanus Neurotoxins Annu Rev Biochem. 2019 Jun 20;88:811-837._x000D_ 6: Lúquez C, Halpin JL, Dykes J. Unintended consequences: Renaming botulinum neurotoxin-producing species of clostridium and related species Toxicon. 2023 Mar 1;224:107036._x000D_ 7: Hull M, Parnes M, Jankovic J. Botulinum Neurotoxin Injections in Childhood Opisthotonus Toxins (Basel). 2021 Feb 12;13(2):137._x000D_ 8: Sugiyama H. Clostridium botulinum neurotoxin Microbiol Rev. 1980 Sep;44(3):419-48._x000D_ 9: Jost WH, Berberovic E. Therapy with botulinum neurotoxin for Parkinson's disease J Neural Transm (Vienna). 2024 Nov;131(11):1321-1328._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33503872">10: Jost WH. Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal Toxins (Basel). 2021 Jan 25;13(2):87. </a>_x000D_ _x000D_ <strong>Products Related to Botulinum Neurotoxin (BoNT) B Substrate Modification (amide) - FITC labeled can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>